TCM
DMTK

Triumph Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Triumph Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,792
Closed -$508K – 216
2021
Q2 		$508K Buy
+14,792
New +$608K 0.3% 84

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Triumph Capital Management's DMTK Position: Q3 2021 in Review

Triumph Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 14,792 shares — an estimated $508K sold.

Triumph Capital Management first reported a position in DMTK in Q2 2021 and held it in 1 quarter. The position peaked at $508K in Q2 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Triumph Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Triumph Capital Management sold 14,792 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $508K.
  • Triumph Capital Management first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Triumph Capital Management's DermTech, Inc. Common Stock position peaked at $508K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Triumph Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.